GSK plc Cash Flows From Used In Financing Activities
GSK plc (GLAXF) reported Cash Flows From Used In Financing Activities of -GBP 3.69 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2026-03-06
| Period end | Cash Flows From Used In Financing Activities 12 month |
|---|---|
| 2025-12-31 | -3.69B GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | -4.73B GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | -5.64B GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | 823.00M GBP 20-F · filed 2025-03-03 |
| 2021-12-31 | -7.59B GBP 20-F · filed 2024-03-05 |
| 2020-12-31 | -10.13B GBP 20-F · filed 2023-03-10 |
| 2019-12-31 | -1.84B GBP 20-F · filed 2022-03-08 |
| 2018-12-31 | -6.39B GBP 20-F · filed 2021-03-12 |
| 2017-12-31 | -6.38B GBP 20-F · filed 2020-03-06 |
| 2016-12-31 | -6.39B GBP 20-F · filed 2019-03-15 |
| 2015-12-31 | -7.10B GBP 20-F/A · filed 2018-03-20 |